发明名称 PHARMACEUTICAL COMPOSITION FOR THE STIMULATION OF LYMPHATIC NEOVASCULARIZATION COMPRISING HUMAN BLOOD DERIVED HEMATOSPHERE
摘要 The present invention relates to a method for stimulating lymphatic neovascularization by effectively culturing and multiplying lymph vessel adult stem cells and precursor cells, which are present in blood in a very small amount, using blood mononuclear cells; and use thereof. The present invention provides a pharmaceutical composition for stimulating lymphatic neovascularization, comprising human-blood-derived hematosphere etc. Therefore, the present invention provides a method for massively culturing and multiplying lymph vessel adult stem cells and precursor cells via the in vitro culture of self-derived blood monocyte; and a method for treating diseases having lymph vessel formation abnormality and disorder using the same. The present invention enables the massive securing of blood lymph vessel adult stem cells and precursor cells and can contribute to developing an optimal autologous-cell-derived cell therapy agent for cell therapy for lymph-vessel-related diseases.
申请公布号 KR20140021155(A) 申请公布日期 2014.02.20
申请号 KR20120086958 申请日期 2012.08.08
申请人 SNU R&DB FOUNDATION 发明人 PARK, YOUNG BAE;KIM, HYO SOO;HUR, JIN;JANG, JAE HEE;CHOI, JAE IL
分类号 A61K35/14;A61K35/12;A61P17/02 主分类号 A61K35/14
代理机构 代理人
主权项
地址